Search research articles
Contact Us
Filters
Showing results (121-130 of 218) with videos related to
Page
of 22
Sort By:
Clinical Colorectal Cancer
|
May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
Francesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
Future Oncology (London, England)
|
February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma
Manish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
International Journal of Surgery (London, England)
|
November 13, 2025
Resection margin strategy and surgical practices in gastric cancer surgery: the European REMARCS (Resection MARgin for cancer of the stomach) survey
Mickael Chevallay, Felix Berlth, Maria Bencivenga, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
JCO Precision Oncology
|
June 1, 2024
PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays
Samuel J Klempner, Eric S Cowden, Samuel L Cytryn, et al.
Oncology Research and Treatment
|
February 19, 2026
What is new in the German S3 guideline on gastric cancer: diagnosis, staging and treatment
Markus Moehler, Yvonne Huber, Jan Bornschein, et al.
Journal of Clinical Medicine
|
July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
Simon Johannes Gairing, Felix Thol, Lukas Müller, et al.
BMC Cancer
|
June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
Michael Stahl, Annett Maderer, Florian Lordick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2025
Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab
Markus Moehler, Harry H Yoon, Daniel-Christoph Wagner, et al.
Page
of 22
Search research articles
Search
Showing results (121-130 of 218) with videos related to
Sort By:
Page
of 22
Clinical Colorectal Cancer
|
May 31, 2022
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group
Francesco Sclafani, Elisa Fontana, Lucjan Wyrwicz, et al.
Future Oncology (London, England)
|
February 3, 2021
KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma
Manish A Shah, Jaafar Bennouna, Toshihiko Doi, et al.
International Journal of Surgery (London, England)
|
November 13, 2025
Resection margin strategy and surgical practices in gastric cancer surgery: the European REMARCS (Resection MARgin for cancer of the stomach) survey
Mickael Chevallay, Felix Berlth, Maria Bencivenga, et al.
BMC Cancer
|
April 14, 2017
Systemic therapy in younger and elderly patients with advanced biliary cancer: sub-analysis of ABC-02 and twelve other prospective trials
Mairéad Geraldine McNamara, John Bridgewater, Andre Lopes, et al.
JCO Precision Oncology
|
June 1, 2024
PD-L1 Immunohistochemistry in Gastric Cancer: Comparison of Combined Positive Score and Tumor Area Positivity Across 28-8, 22C3, and SP263 Assays
Samuel J Klempner, Eric S Cowden, Samuel L Cytryn, et al.
Oncology Research and Treatment
|
February 19, 2026
What is new in the German S3 guideline on gastric cancer: diagnosis, staging and treatment
Markus Moehler, Yvonne Huber, Jan Bornschein, et al.
Journal of Clinical Medicine
|
July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic Cholangiocarcinoma
Simon Johannes Gairing, Felix Thol, Lukas Müller, et al.
BMC Cancer
|
June 19, 2023
Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)
Sylvie Lorenzen, Alix Schwarz, Claudia Pauligk, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 5, 2018
Perioperative chemotherapy with or without epidermal growth factor receptor blockade in unselected patients with locally advanced oesophagogastric adenocarcinoma: Randomized phase II study with advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)
Michael Stahl, Annett Maderer, Florian Lordick, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 15, 2025
Concordance Between the PD-L1 Tumor Area Positivity Score and Combined Positive Score for Gastric or Esophageal Cancers Treated With Tislelizumab
Markus Moehler, Harry H Yoon, Daniel-Christoph Wagner, et al.
Page
of 22